These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11489482)

  • 21. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K; Obuchi M; Honda M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.
    Ohtsuka N; Konno T; Miyauchi Y; Maeda H
    Cancer; 1987 May; 59(9):1560-5. PubMed ID: 3030530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y; Nakamura H
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Passive tumor targeting of soluble macromolecules and drug conjugates.
    Seymour LW
    Crit Rev Ther Drug Carrier Syst; 1992; 9(2):135-87. PubMed ID: 1386002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.
    Iwai K; Maeda H; Konno T
    Cancer Res; 1984 May; 44(5):2115-21. PubMed ID: 6324996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
    Yoshida H; Onda M; Tajiri T; Uchida E; Arima Y; Mamada Y; Yamamoto K; Kaneko M; Terada Y; Kumazaki T
    Hepatogastroenterology; 1999; 46(28):2612-5. PubMed ID: 10522050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].
    Umeda S; Ito K; Takahashi E; Kimura F; Sumitomo M; Kaji T; Hayakawa M; Asano T
    Hinyokika Kiyo; 2010 Oct; 56(10):543-9. PubMed ID: 21063157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation.
    Suzuki F; Matsumoto K; Schmitt DA; Pollard RB; Maeda H
    Int J Immunopharmacol; 1993 Feb; 15(2):175-83. PubMed ID: 7682198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our initial experience with SMANCS in TAE for liver cancer].
    Fujita M; Inoue E; Kuroda C; Kasugai H; Sasaki Y; Nakano H; Imaoka S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tumor selective drug delivery with lipid contrast medium (smancs/lipiodol): sustained antitumor effect, enhanced diagnostic value and quantification of dosage regimen].
    Maeda H; Konno T; Iwai K; Maki S; Tashiro S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):814-26. PubMed ID: 6326681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
    Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathologic study of hepatocellular carcinoma treated by TAI and TAE with SMANCS].
    Takayasu K; Iwata R; Furukawa T; Nakanishi Y; Sakamoto M
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():70-2. PubMed ID: 9512691
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor-targeted chemotherapy with lipid contrast medium and macromolecular anticancer drug (SMANCS) for renal cell carcinoma.
    Kobayashi M; Imai K; Sugihara S; Maeda H; Konno T; Yamanaka H
    Urology; 1991 Mar; 37(3):288-94. PubMed ID: 1848030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein].
    Yamasaki K; Konno T; Miyauchi Y; Maeda H
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1224-8. PubMed ID: 3034169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H; Sogabe M; Tsutsui A; Yokoi T; Morimoto M; Fukuda T; Hayashi S; Muguruma N; Ohkita Y; Okahisa T; Okamura S; Ito S
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of hepatic metastases in rabbits by administration of an oily anticancer agent into the portal vein.
    Yamasaki K; Konno T; Miyauchi Y; Maeda H
    Cancer Res; 1987 Feb; 47(3):852-5. PubMed ID: 3026619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M; Ebara M; Fukuda H; Sugiura N; Saisho H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma--second report].
    Hirashima N; Itazu I; Nukaya H; Kimura H; Hasegawa I; Yoshimizu T; Nemoto S; Sakakibara K
    Gan To Kagaku Ryoho; 1998 May; 25(6):873-9. PubMed ID: 9617326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T; Maeda H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.